Charles River Laboratories International (CRL) Revenue — Quarter Ended Jun 29, 2024
This quarter's revenue increased compared to the immediately preceding quarter but declined compared to the same quarter one year earlier. The sequential improvement marks a reversal from the prior quarter's performance.
Key takeaway
Quarter ended Jun 29, 2024 · FY2024 Q2
This quarter's revenue increased compared to the immediately preceding quarter but declined compared to the same quarter one year earlier. The sequential improvement marks a reversal from the prior quarter's performance.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1B
Revenue reported for this quarter.
Quarter-over-quarter
+1.4%
Change from the immediately preceding quarter.
Year-over-year
-3.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $1B | +3.8% |
| Dec 30, 2023 | $1B | -7.9% |
| Mar 30, 2024 | $1B | -1.7% |
| Jun 29, 2024 | $1B | -3.2% |
Revenue performance
Revenue rose from the prior quarter, driven by factors not specified in the filing. However, on a year-over-year basis, revenue was lower.
Quarterly comparison
Compared to the preceding quarter, revenue showed growth. In contrast, when measured against the same quarter last year, revenue decreased.
What to watch
The year-over-year decline continues a pattern of negative comparisons seen in recent quarters.